ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,074Medicare Part D Prescriptions Filled, Including Refills

Rank: 487 out of 1844

$423K Total Retail Price of All Prescriptions

Rank: 492 out of 1844

353 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 353 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

26% of this provider’s 353 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 4,461 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 503 236 S3 1 2
AMLODIPINE BESYLATE 288 195 2 6
SIMVASTATIN 248 181 3 3
OMEPRAZOLE 246 147 4 5
LEVOTHYROXINE SODIUM 230 177 5 1
METFORMIN HCL 176 124 6 8
ATORVASTATIN CALCIUM 166 110 7 12
FUROSEMIDE 145 90 8 7
LISINOPRIL 142 93 9 4
WARFARIN SODIUM 142 113 9 13
ZOLPIDEM TARTRATE 128 84 11 23
MELOXICAM 121 77 12 28
GABAPENTIN 103 58 13 15
METOPROLOL SUCCINATE 96 59 14 14
CARVEDILOL 94 70 15 22
CITALOPRAM HBR 83 67 16 19
METOPROLOL TARTRATE 82 78 17 11
PANTOPRAZOLE SODIUM 76 50 18 32
TRAMADOL HCL 75 31 19 18
TAMSULOSIN HCL 71 66 20 27
ALENDRONATE SODIUM 69 69 21 25
ISOSORBIDE MONONITRATE ER 64 37 22 59
GLIPIZIDE 63 46 23 70
NIASPAN 63 0 23 162
NEXIUM 62 31 25 31
SPIRIVA 61 44 26 57
CLOPIDOGREL 59 49 27 34
POTASSIUM CHLORIDE 59 32 27 16
ATENOLOL 57 44 29 17
CRESTOR 57 42 29 30
LISINOPRIL-HYDROCHLOROTHIAZIDE 56 20 31 20
LOVASTATIN 56 38 31 44
PLAVIX 55 41 33 61
AZITHROMYCIN 53 28 34 37
HYDROCHLOROTHIAZIDE 52 51 35 9
PRAVASTATIN SODIUM 51 27 36 10
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 25, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.